What is the overall Global Colorectal Cancer Drug Market size?

The Global Colorectal Cancer Drug Market size is valued at USD 11.97 billion in 2023.

What is the projected Global Colorectal Cancer Drug Market growth under the study period?

The worldwide Global Colorectal Cancer Drug Market growth is estimated to be 4.1% from 2024 to 2030.

What is the Global Colorectal Cancer Drug Market segmentation covered in the report?

Global Colorectal Cancer Drug Market segmentation covered in the report is By Drug Type (Vascular Endothelial Growth Factor (VEGF) Inhibitors, Programmed Cell Death Protein 1 (PD-1)/PD-Ligand 1 (PD-L1) Inhibitors, Tyrosine Kinase Inhibitors (TKIs), Immunomodulators, BRAF or MEK Inhibitors, Chemotherapy Drugs, Others); By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others); By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and by region.

What are the potential future trends and opportunities for the Global Colorectal Cancer Drug Market?

The possible spike in cases that are discovered after the drop in screenings during COVID-19 is anticipated to propel growth in the global colorectal cancer medication market. More effective therapies may be possible thanks to developments in fields like AI-powered drug discovery and personalized medicine.

What impact has the COVID-19 pandemic had on the Global Colorectal Cancer Drug Market?

The COVID-19 pandemic delayed tests and treatments, which affected the colorectal cancer drug market. However, it may have also spurred innovation in substitute therapy modalities. As more cases are found, this can cause the need for medications to rise in the future.

Colorectal Cancer Drug Market | Size, Share, Growth

Global Colorectal Cancer Drug Market Research Report - Segmented By Drug Type (Chemotherapy (Alkylating Agents, Antimetabolites, Plant Alkaloids, Topoisomerase Inhibitors), Targeted Therapy (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, mTOR Inhibitors, VEGF Inhibitors, Small Molecule Inhibitors), Immunotherapy (Immune Checkpoint Inhibitors, Cancer Vaccines, Non-Specific Immunotherapies, Recombinant Fusion Proteins), Hormonal Therapy, Gene Therapy, Others); By Drug Class (Cytotoxic Agents, Hormonal Agents, Biologics); By Molecular Target (EGFR Inhibitors, HER2 Inhibitors, BRAF Inhibitors, PD-1/PD-L1 Inhibitors, VEGF Inhibitors, Others); By Route of Administration (Oral, Intravenous, Subcutaneous, Parenteral, Topical); By Line of Treatment (First-Line Treatment, Second-Line Treatment, Advanced Line Treatment); By Patient Age Group (Paediatric, Adult, Geriatric); By End-User( Hospitals, Specialty Clinics, Cancer Research Centres, Others (Homecare, Ambulatory Surgical Centres)), and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)

Published: 2024 - Jul

Report Code: VMR-17246

Region: Global

Historic Range: 2021-2023

Forecast: 2024-2030

Format: Excel and PDF

❓ Enquire Before Buying

Fill out the form below and our team will get back to you shortly

The field with (*) is required.

📋 Contact Information

Name *

Email *

Company *

Job Title *

Country *

Phone *

Message (Optional)

Security Verification

This form is protected by Google reCAPTCHA v3. Verification runs automatically when you submit.

Your information is secure and will not be shared with third parties.

Select User License Type

Data Spreadsheet: Market data delivered in spreadsheet format for analysis.

Single User: One named user; PDF report access for internal use.

Multi User: Up to five users within the same organization at one location.

Corporate User: Enterprise-wide access across your organization.

Data Spreadsheet

2500

Single User

4250

Multi User

5250

Corporate User

6900

Country-Specific Report

Dive into Country Outlook

Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.

Access Country Insights

Testimonials

“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”

Medical Devices Company based in Europe